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Tumor necrosis factor (TNF)-a is quickly released and initiates inﬂammation at wound tissues, but its precise role in wound healing is
not fully understood. We examined the contribution of this cytokine to the early process of healing using a mouse model with full-
thickness wounds in skin. TNF-a synthesis was detected just after wound creation, increased during the ﬁrst several hours, reached a
peak level on day 1, and then decreased to the basal level. In mice treated with anti-TNF-a mAb, wound closure was signiﬁcantly
delayed, and distances between the panniculus carnosus edges were signiﬁcantly longer on day 3, compared with control. Inﬂammatory
cell and ﬁbroblast density were markedly decreased on day 3 in the anti-TNF-a mAb-treated mice compared with control. In contrast,
wound healing was accelerated on day 3 when mice were treated with bioactive TNF-a. These results indicate that TNF-a is involved in
the early process of wound healing.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Skin has the capacity to repair damaged or lost tissues by
regenerating tissues and forming a collagenous scar. This
process is called ‘‘wound healing” (Robson et al., 2001)
and consists of coagulation, inﬂammation, proliferation
and remodeling phases, in which a variety of cytokines
and growth factors, such as interleukin (IL)-1b, tumor
necrosis factor (TNF)-a, transforming growth factor
(TGF)-b, epidermal growth factor (EGF), platelet-derived
growth factor (PDGF) and basic ﬁbroblast growth factor
(bFGF) are produced (Rumalla and Borah, 2001; Mast
and Schultz, 1996; Barrentos et al., 2008). Both immunebehalf of King Saud University.
ommons.org/licenses/by-nc-nd/4.0/).
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ﬁbroblasts, vascular endothelial cells and keratinocytes, are
involved in this process. Among these cytokines, TNF-a is
quickly released by vascular endothelial cells, keratinocytes
and ﬁbroblasts in the injured area, and this initiates the
inﬂammatory phase by promoting inﬂammatory leukocyte
recruitment into the wounded tissues (Mast and Schultz,
1996). In the inﬂammatory phase, major cellular sources
of TNF-a are changed into recruited neutrophils and
macrophages, and this process yields a positive ampliﬁca-
tion circuit for extending the inﬂammatory responses
(Mast and Schultz, 1996; Barrentos et al., 2008; Eming
et al., 2007). In addition, TNF-a regulates the activity of
ﬁbroblasts, vascular endothelial cells and keratinocytes,
and the synthesis of extracellular matrix proteins and
matrix metalloproteinases, which are closely involved in
the healing of injured tissues (Mast and Schultz, 1996).
In the present study, we investigated the eﬀect of sup-
pressing TNF-a biological activity on the healing process
of full thickness wounds created in the skin of mice.
TNF-a biological activity was suppressed by neutralizing
monoclonal antibodies (mAb). In addition, we also tested
how this process was aﬀected by administering bioactive
TNF-a. We found that TNF-a played an important role
in the early process of wound healing in the skin.2. Materials and methods
2.1. Animals
ICR mice were obtained from Clea Japan, Inc. (Tokyo,
Japan). Mice were subjected to experiments at 7–10 weeks
of age. To minimize possible discomfort to animals, m-
acetamidophenol (0.4 mg/mouse/day) was administered in
the drinking water during the experimental period. All
experimental protocols described in the present study were
approved by our university’s Ethics Review Committee for
Animal Experimentation.2.2. Wound creation and tissue collection
Mice were anesthetized by intraperitoneal injection of
40 mg/kg sodium pentobarbital (NEMBTAL Injection,
Dainippon Sumitomo Pharma, Osaka, Japan). The dorsal
hairs were shaved to fully expose the skin, which was then
rinsed with 70% ethanol. Six full-thickness wounds extend-
ing to the panniculus carnosus were created using a 3-mm
diameter biopsy punch (Biopsy Punch, Kai industries Co.,
Ltd., Gifu, Japan) under sterile conditions. The six wounds
per mouse were at least 5 mm apart. The injured areas were
covered with a polyurethane ﬁlm (Tegaderm Transparent
Dressing, 3 M Health Care, St. Paul, MN) and an elastic
adhesive bandage (Hilate, Iwatsuki, Tokyo, Japan) as an
occlusive dressing. At various time points, mice were sacri-
ﬁced and the wound tissues were collected by excising the
area with an 8-mm diameter biopsy punch. The tissueswere processed for histological analysis and measurement
of cytokine concentrations.
2.3. Reagents and antibodies
Anti-TNF-a mAb was puriﬁed using a protein G col-
umn kit (Kirkegaard & Perry Lab., Gaithersburg, MD)
from the culture supernatants of hybridoma cells (clone
MP6-XT2.2-11, provided by Dr. Akio Nakane, Depart-
ment of Microbiology and Immunology, Hirosaki Univer-
sity Graduate School of Medicine, Hirosaki, Japan). To
neutralize TNF-a biological activity, mice were injected
intraperitoneally with mAb against this cytokine at
400 lg one day prior to and three days after wound cre-
ation. Rat IgG (ICN Pharmaceuticals, Inc., Aurora, OH)
was used as the control Ab. An amount of 25 lg/kg
TNF-a, puriﬁed from a human B-cell lymphoblastoid cell
line (BALL-1, Hayashibara Biochemical Laboratories
Inc., Okayama, Japan), was injected into the peritoneal
cavity once daily beginning on the day of wound creation
(Fukuda et al., 1998). PBS was used as the control vehicle.
2.4. Measurement of wound area
Morphometric analysis was performed on digital images
obtained using a digital camera (QV-2800UX, Casio,
Tokyo, Japan). After the wounds were created, pho-
tographs were taken of each wound before dressing. At
various time points, the polyurethane ﬁlms were gently
removed from the experimental mice, and the wounds were
photographed. The wound area was quantiﬁed by tracing
its margin and calculating the pixel area using AxioVision
imaging software Release 4.6 (Carl Zeiss Micro Imaging
Japan, Tokyo, Japan). Wound size at any given time point
after the initial wound creation was expressed as a percent-
age of the original wound area.
2.5. Measurement of cytokine concentrations
Wound tissues were homogenized in PBS, and the
TNF-a concentration in the supernatant was measured
using an enzyme-linked immunosorbent assay (ELISA)
kit (Endogen, Cambridge, MA). The results were expressed
as the values per one wound. The detection limit was
5.1 pg/ml.
2.6. Histological analysis
Wound tissues were collected using an 8-mm diameter
biopsy punch and were dissected in a caudocranial
direction. The tissues were ﬁxed with 4%
paraformaldehyde-phosphate buﬀer solution and embed-
ded in paraﬃn. Sections 2 lm in thickness were harvested
from the central portion of the wound and stained with
hematoxylin-eosin (HE), according to the standard
method. The distance between the edges of the panniculus
carnosus was measured to determine the degree of wound
contraction on the HE-stained paraﬃn section.
Figure 2. TNF-a concentration in wounded tissue homogenate TNF-a
concentration in the wound tissue homogenate was measured at 0 and 6 h
and on days 1, 3, 5, 7 and 14 after wound creation. Each column
represents the mean ± SD of 3 homogenates, each of which was prepared
from 6 wounds.
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Data are expressed as mean ± standard deviation (SD).
Statistical analysis between groups was performed using
the Student’s t test. A p value less than 0.05 was considered
signiﬁcant.
3. Results
3.1. Skin wound healing and local TNF-a production
For the animal model of skin wound healing, we created
full thickness wounds in the backs of mice and observed the
condition of the wounds at various time intervals. On
macroscopic observation, the wounds showed steady clo-
sure in a time-dependent manner, decreasing by 80% in size
by day 14, without eschars, exudative ﬂuids and any signs
of infection (Fig. 1A and B). We next measured the TNF-a
concentration in the homogenate supernatants of the col-
lected wounds at various time intervals. As shown in
Fig. 2, TNF-a was detected just after wound creation,
and rapidly increased in concentration during the ﬁrst sev-
eral hours. The peak concentration level was reached on
day 1, and levels declined thereafter to the basal level.Figure 1. A mouse model of wound healing Wounds were created in the backs o
and 14 after wound creation. The images (A) and percentages of original woun
of 24 wounds.3.2. Eﬀect of anti-TNF-a mAb on wound healing
To address the role of TNF-a in wound healing, we
examined the eﬀect of neutralizing anti-TNF-a mAb on
this process. As shown in Fig. 3A, in mice treated withf ICR mice using biopsy punches. Wounds were observed on days 1, 3, 5, 7
d area (B) are shown for each day. Each column represents the mean ± SD
Figure 3. Eﬀect of anti-TNF-a mAb treatment on wound healing Mice were treated with anti-TNF-a mAb (400 lg/mouse) or control IgG
(400 lg/mouse). (A) The wound area size was evaluated on days 3 and 7. Each column represents the mean ± SD of 18 to 24 wounds. NS, not signiﬁcant;
*p < 0.05. (B, C) The distance between the edges of the panniculus carnosus on the HE stained paraﬃn sections was evaluated on day 3. Each column
represents the mean ± SD of 8–10 sections. Arrows indicate the edges of panniculus carnosus. PC, panniculus carnosus; *p < 0.05. (D) Inﬂammatory cell
and ﬁbroblast density on the HE stained paraﬃn section was markedly decreased in the anti-TNF-amAb-treated mice compared with control mice on day
3. Arrows indicate ﬁbroblasts.
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Figure 4. Eﬀect of TNF-a administration on wound healing. Mice were treated with puriﬁed TNF-a (25 lg/kg) or PBS, and wound areas were evaluated
on days 3 and 7. Each column represents the mean ± SD of 18–24 wounds. NS, not signiﬁcant; *p < 0.05.
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on day 3 compared with that in control mice treated with
rat IgG, although the size of the original wound area was
not signiﬁcantly diﬀerent between both groups on day 7.
These macroscopic ﬁndings were conﬁrmed by histological
assessment. As shown in Fig. 3B and C, HE-stained paraf-
ﬁn sections representing the longitudinal diameter of the
wound showed signiﬁcantly shorter distances between the
edges of the panniculus carnosus in treated mice compared
with control animals on day 3. In addition, on day 3 after
wound creation in the anti-TNF-a mAb-treated mice, the
density of inﬂammatory cells and ﬁbroblasts was markedly
decreased when compared with control mice (Fig. 3D).
3.3. Eﬀect of TNF-a administration on wound healing
To further elucidate the role of TNF-a, we tested
whether administration of this cytokine aﬀected the wound
healing process. As shown in Fig. 4, this treatment resulted
in a signiﬁcant promotion of wound closure compared with
PBS treatment on day 3, but not on day 7.
4. Discussion
The major ﬁndings in the present study are as follows:
(1) TNF-a production was detected in the homogenate of
wound tissues with a peak level on day 3 after wound cre-
ation; (2) wound healing was signiﬁcantly delayed on day
3, but not on day 7, in mice treated with anti-TNF-a
mAb compared with mice that received control IgG; and
(3) TNF-a accelerated wound repair on day 3, but not on
day 7. These results indicate that TNF-a is closely involved
in the very early process of wound healing in skin.
TNF-a was produced in the wounded tissues and
reached a peak level on day 1, after which it returned to
the basal level. However, this increase in TNF-a level
was not statistically signiﬁcant even at the time point of
maximal production. This may be a result of the high
TNF-a level detected just after wounding (0 h), whichmay make the relatively small production of this cytokine
less clear. In our unpublished data, TNF-a was constitu-
tively detected in the skin tissues taken from mice that
did not undergo any treatment. Also, in previous studies,
pro-inﬂammatory cytokines including TNF-a were
detected at the mRNA level using RT-PCR, particularly
in epidermal cells, using in-situ hybridization (Sato and
Ohshima, 2000; Takacs et al., 1998). This constitutive
expression of TNF-a is thought to be involved in the regu-
lation of homeostasis in skin tissue (Mckay and Leigh,
1991). Thus, TNF-a levels measured in the wound tissues
were likely higher than the normal basal levels, which sug-
gests that this cytokine may be involved in the process of
wound healing.
In support of this hypothesis, treatment with neutraliz-
ing anti-TNF-a mAb resulted in a delay in wound closure
and administration of bioactive TNF-a resulted in promo-
tion of wound closure, particularly during the early phase.
In addition, closure of the panniculus carnosus was delayed
by treating the wounded mice with neutralizing
anti-TNF-a mAb. During the proliferation phase in the
wound healing process, TNF-a secreted from macrophages
promotes the formation of the extracellular matrix in the
wounded tissues by inducing the generation of proteogly-
can and ﬁbronectin by ﬁbroblasts. This process is further
enhanced by collagen synthesis from the proliferating
ﬁbroblasts, which are promoted by TGF-b. Thus, pro-
teases secreted by macrophages and ﬁbroblasts are closely
involved in the generation of bioactive TGF-b from pro-
TGF-b, which is produced by ﬁbroblasts (Witte and
Barbul, 1997). On the other hand, it is well known that
TGF-b1 and PDGF produced by macrophages stimulate
the generation of myoﬁbroblasts from some ﬁbroblasts,
which results in the contraction of the extracellular matrix
and subsequent wound closure (Desmouliere et al., 1993;
Yang et al., 1997). These earlier ﬁndings and those of our
present study suggest that neutralization of bioactive
TNF-a may delay closure of the panniculus carnosus and
overall wound healing by interfering with the proliferation
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created by these cells.
In the present study, the cellular source of TNF-a pro-
duction remains to be determined. Because TNF-a was
detected quickly after wound creation, non-immune cells,
such as keratinocytes and ﬁbroblasts, and innate immune
cells, such as neutrophils and macrophages, may contribute
to synthesis of this cytokine. Further investigation is neces-
sary to address this issue.5. Conclusion
We demonstrated that TNF-a plays a crucial role in the
early process of wound healing in skin and that TNF-a
administration had a beneﬁcial eﬀect on this response.
Thus, the current ﬁnding may lead to development of a
novel therapeutic strategy for chronic skin wounds, such
as intractable decubitus, in which the wound healing pro-
cess is impaired.Conflict of interest
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